➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Patent Applications for ALECENSA

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

US Patent Applications for ALECENSA

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial TETRACYCLIC COMPOUND 2011-12-09 Patented Case 2015-08-19
  Start Trial   Start Trial COMPOSITION COMPRISING TETRACYCLIC COMPOUND 2013-02-13 Publications -- Issue Fee Payment Received 2016-05-11
  Start Trial   Start Trial TETRACYCLIC COMPOUND 2015-02-11 Publications -- Issue Fee Payment Verified 2016-07-29
  Start Trial   Start Trial RET INHIBITOR 2015-03-20 Final Rejection Mailed 2018-04-26
  Start Trial   Start Trial TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR 2015-04-07 Docketed New Case - Ready for Examination 2017-10-13
  Start Trial   Start Trial DEUTERATED ALK INHIBITORS 2015-06-18 Abandoned -- Failure to Respond to an Office Action 2016-12-23
  Start Trial   Start Trial Treatment of Cancer 2015-08-18 Abandoned -- Failure to Pay Issue Fee 2018-02-13
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.